Literature DB >> 7040173

Immunohistochemical evaluation of carcinoembryonic antigen, secretory component, and epithelial IgA in ulcerative colitis with dysplasia.

T O Rognum, K Elgjo, O Fausa, P Brandtzaeg.   

Abstract

Immunofluorescence staining for carcinoembryonic antigen, secretory component, and epithelial IgA was evaluated semiquantitatively in routine formalin-fixed mucosal biopsy samples from five patients with ulcerative colitis who had undergone colectomy because of carcinomas. Selected areas were given fluorescence intensity scores without knowledge of whether dysplasia or reactive hyperplasia was present as judged by another observer from conventional histopathological features in adjacent sections. The two types of lesion did not differ significantly with regard to the expression of the three marker antigens. In a prospective study based on cold ethanol-fixed mucosal biopsy samples, lesions from 11 ulcerative colitis patients with dysplasia were compared blindly with lesions from six patients with reactive hyperplasia and with samples obtained endoscopically from eight normal controls. The range of disease-associated fluorescence intensity scores was wide, but staining for all markers tended to be brighter in reactive hyperplasia than in dysplasia (P less than 0.01). In the controls, the fluorescence intensity score tended to be lower for carcinoembryonic antigen but was significantly (P less than 0.01) higher for secretory component and epithelial IgA than in both types of lesion. Moreover, staining for secretory component and epithelial IgA in the lesions seemed to be inversely related to the grade of dysplasia and the degree of inflammation. No such trend was seen for carcinoembryonic antigen. The wide ranges of individual fluorescence scores precluded the possibility of applying carcinoembryonic antigen, secretory component, and epithelial IgA as immunohistochemical markers to differentiate between dysplasia and reactive hyperplasia in routine diagnostic work.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040173      PMCID: PMC1419544          DOI: 10.1136/gut.23.2.123

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

2.  The development of carcinoma of the large intestine in ulcerative colitis.

Authors:  I M DAWSON; J PRYSE-DAVIES
Journal:  Br J Surg       Date:  1959-09       Impact factor: 6.939

3.  Pathogenesis of ulcerative colitis.

Authors:  S WARREN; S C SOMMERS
Journal:  Am J Pathol       Date:  1949-07       Impact factor: 4.307

4.  "Precancer" lesions in ulcerative colits. A retrospective study of rectal biopsy and colectomy specimens.

Authors:  J H Yardley; D F Keren
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

5.  Carcinoma and epithelial dysplasia complicating ulcerative colitis.

Authors:  M G Cook; J C Goligher
Journal:  Gastroenterology       Date:  1975-05       Impact factor: 22.682

6.  An optical and ultrastructural study of the localization of carcinoembryonic antigen (CEA) in normal and cancerous human rectocolonic mucosa.

Authors:  E Huitric; R Laumonier; P Burtin; S Von Kleist; G Chavanel
Journal:  Lab Invest       Date:  1976-01       Impact factor: 5.662

7.  Abnormalities of the local immune system in intestinal neoplasia: a morphological study.

Authors:  F H Green; S Whitehead; H Fox
Journal:  J Pathol       Date:  1977-06       Impact factor: 7.996

8.  Tissue demonstration of carcinoembryonic antigen (CEA) in ulcerative colitis.

Authors:  P Isaacson
Journal:  Gut       Date:  1976-07       Impact factor: 23.059

Review 9.  Relationships between immunoglobulins and the intestinal epithelium.

Authors:  W R Brown
Journal:  Gastroenterology       Date:  1978-07       Impact factor: 22.682

10.  Fluorescence staining of gastric mucosa. A study with special reference to parietal cells.

Authors:  R Stave; P Brandtzaeg
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

View more
  12 in total

1.  Mixed hyperplastic and neoplastic polyp of the colon. An immunohistological study.

Authors:  J O Gebbers; J A Laissue
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Role of local cytokines in increased gastric expression of the secretory component in Helicobacter pylori infection.

Authors:  I Ahlstedt; C Lindholm; H Lönroth; A Hamlet; A M Svennerholm; M Quiding-Järbrink
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis.

Authors:  D Islam; B Veress; P K Bardhan; A A Lindberg; B Christensson
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

4.  Measurement of total, monomeric and polymeric IgA in human faeces by electroimmunodiffusion.

Authors:  D Meillet; D Raichvarg; F Tallet; J Savel; J Yonger; J G Gobert
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

5.  The polymeric immunoglobulin receptor (secretory component) in a human intestinal epithelial cell line is up-regulated by interleukin-1.

Authors:  M Hayashi; N Takenouchi; M Asano; M Kato; T Tsurumachi; T Saito; I Moro
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

6.  Immunofluorescence study of secretory epithelial markers in pleomorphic adenomas.

Authors:  F R Korsrud; P Brandtzaeg
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

7.  Local immunity in ulcerative colitis: evidence for defective secretory IgA production.

Authors:  S Badr-el-Din; L K Trejdosiewicz; R V Heatley; M S Losowsky
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

8.  Decreased mucosal IgA levels in ileum of patients with chronic ulcerative colitis.

Authors:  L Cicalese; R H Duerr; M A Nalesnik; P F Heeckt; K K Lee; W H Schraut
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

9.  An immunoperoxidase study of epithelial marker antigens in ulcerative colitis with dysplasia and carcinoma.

Authors:  D C Allen; J D Biggart; J C Orchin; H Foster
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

10.  Secretory component mRNA and protein expression in colorectal adenomas and carcinomas.

Authors:  P Krajci; G I Meling; S N Andersen; B Hofstad; M H Vatn; T O Rognum; P Brandtzaeg
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.